Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingre Huashi Granules with Modified Dual Therapy for H. pylori in Elderly
NCT05364619Unknown
- Sponsor
- Peking University First Hospital
- Start
- Aug 2022
- Primary completion
- Dec 2024
- Modality
- Herbal Formulation, TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Randomised, open-label trial of Qingre Huashi decoction in Helicobacter pylori infection (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Helicobacter pylori eradication rate. Status: unknown.
02
Drugs
Qingre Huashi decoction
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05364619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05364619.